We will never end the death and destruction of COVID-19 until we get real about vaccine equity. In a month of high-level meetings from the G7 to the World Health Assembly, we have seen a lot of rhetoric from the global north, ...
Jun 21, 2021
0
1
Cerebral aneurysms are malformations caused by abnormalities on the walls of blood vessels in the brain. When these blood vessels rupture, about 30% of patients die on the spot. Recently, a research team at POSTECH has come ...
May 10, 2021
0
5
The International Federation of Pharmaceutical Manufacturers and Associations expressed disappointment Wednesday at the United States' decision to support a global waiver on patent protections for Covid-19 vaccines.
May 6, 2021
0
4
For women hoping to achieve a pregnancy using freshly retrieved donor eggs, a new retrospective study led by researchers from Brigham and Women's Hospital may provide important insight. Brigham senior author Janis H. Fox, ...
Jan 12, 2021
0
5
Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham, today announced progress towards the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based ...
May 5, 2020
0
7
Dr. Horea Rus is an expert in diagnosing and treating patients with multiple sclerosis, and his research laboratory at the University of Maryland is producing new tools for treating the disease that attacks the central nervous ...
May 8, 2019
0
2
The world's first baby born via in-vitro fertilization turned 40 years old this summer. Still, after four decades, IVF is a relatively new field with ongoing debate on how to get the best results for families who have placed ...
Aug 21, 2018
0
5
Large for gestational age babies and congenital heart defects (CHD) are just two of several risks needing further examination in the emerging field of assisted reproductive technology, according to the editors of a special ...
May 1, 2018
1
3
(HealthDay)—Doctors are spending more than $32,000 per year on health information technology (IT), according to an article published in Medical Economics.
Oct 4, 2016
0
0
"VONVENDI [von Willebrand factor (Recombinant)]", the new drug from Baxalta Incorporated, a global biopharmaceutical company recently spun off from Baxter International, has just been approved by the United States Food and ...
Dec 21, 2015
0
0
